Position in INCY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$38,168,483
+$4,450,183 QoQ
Shares Held
405,530
+18.8% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Derivatives in INCY
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$10,774
PutShares
156
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,945,837,016 across 415 Biotechnology names. INCY ranks #19 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in INCY
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,168,483 | 405,530 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $33,718,300 | 341,382 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $27,511,685 | 324,392 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $21,714,570 | 318,863 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,444,579 | 403,709 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $22,406,515 | 324,403 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $10,774 | 156 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $12,215,543 | 184,804 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $12,155,340 | 200,517 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,001,522 | 228,217 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $19,104,359 | 304,258 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $16,027,708 | 277,440 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $17,987,573 | 288,957 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $18,377,466 | 254,289 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $32,678,673 | 406,856 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $22,715,043 | 340,862 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $21,564,236 | 283,852 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $12,503,884 | 157,440 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $8,377,802 | 114,139 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $8,827,500 | 128,344 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $18,000,202 | 213,957 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $16,632,230 | 204,654 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $25,955,353 | 298,406 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $27,118,799 | 302,193 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $6,861 | 66 | Put | Defined | 2020-08-06 | |
| 2020-06-30 | $32,486,050 | 312,456 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $20,740,565 | 283,225 | Shares | Defined | 2020-05-13 | |
| 2020-03-31 | $4,832 | 66 | Put | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||